What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Elizabeth J. Shpall mostly deals with Transplantation, Immunology, Internal medicine, Hematopoietic stem cell transplantation and Cancer research.
Her research in Transplantation intersects with topics in Ex vivo, Haematopoiesis, Stem cell, Cord blood and Leukemia.
Her Immunology research is multidisciplinary, incorporating elements of Progenitor cell and Cytotoxic T cell.
Her Internal medicine research includes elements of Gastroenterology, Surgery and Oncology.
Her study looks at the intersection of Hematopoietic stem cell transplantation and topics like Fludarabine with Busulfan and Preparative Regimen.
Her study on Cancer research also encompasses disciplines like
- Bone marrow that connect with fields like Platelet Engraftment,
- Stromal cell most often made with reference to Mesenchymal stem cell.
Her most cited work include:
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (1381 citations)
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities (759 citations)
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation (694 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Internal medicine, Transplantation, Immunology, Hematopoietic stem cell transplantation and Surgery.
Her Internal medicine study incorporates themes from Gastroenterology and Oncology.
She has researched Transplantation in several fields, including Progenitor cell, Stem cell, Leukemia and Human leukocyte antigen.
Her study explores the link between Immunology and topics such as Cytotoxic T cell that cross with problems in CD8.
Her study in Hematopoietic stem cell transplantation is interdisciplinary in nature, drawing from both Transplantation Conditioning and Multiple myeloma.
Her Surgery study integrates concerns from other disciplines, such as Preparative Regimen and Urology.
She most often published in these fields:
- Internal medicine (43.63%)
- Transplantation (35.99%)
- Immunology (32.48%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (43.63%)
- Cancer research (15.07%)
- Transplantation (35.99%)
In recent papers she was focusing on the following fields of study:
Internal medicine, Cancer research, Transplantation, Oncology and Hematopoietic stem cell transplantation are her primary areas of study.
Many of her studies on Internal medicine apply to Gastroenterology as well.
The study incorporates disciplines such as Mesenchymal stem cell, Stem cell, Bone marrow and Antigen in addition to Cancer research.
The Stem cell study combines topics in areas such as Immune system and Cord blood.
Her work deals with themes such as Randomized controlled trial, Cyclophosphamide and Maintenance therapy, which intersect with Transplantation.
Her Oncology research integrates issues from Hematopoietic cell, Cancer, Immunotherapy and Lymphoma.
Between 2017 and 2021, her most popular works were:
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (1381 citations)
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities (759 citations)
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors (305 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Her primary scientific interests are in Internal medicine, Cancer research, Immunology, Transplantation and Oncology.
Elizabeth J. Shpall combines topics linked to Gastroenterology with her work on Internal medicine.
Her Cancer research research includes themes of Leukemia, Chronic lymphocytic leukemia, Bone marrow and Antigen.
Elizabeth J. Shpall combines subjects such as Hematopoietic stem cell transplantation and Stem cell with her study of Immunology.
As a part of the same scientific study, Elizabeth J. Shpall usually deals with the Transplantation, concentrating on Hematopoietic cell and frequently concerns with Tyrosine kinase, Lymphoblastic Leukemia, Observational study and Proportional hazards model.
Her biological study spans a wide range of topics, including Cancer, Chimeric antigen receptor, Immunotherapy, Cerebrospinal fluid and Cytarabine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
